VAERS Explorer
Back to explore

Report #2861945

Received Sep 29, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Unknown
Age
65 yrs
State
TX
Recovered
Unknown
Vaccinated
—
Onset
—
Days to onset
—
Hospital days
—

Vaccines (2)

TypeNameManufacturerDoseLotRoute / Site
FLU3INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE)SANOFI PASTEURUNK—OT
FLU3INFLUENZA (SEASONAL) (FLUZONE)SANOFI PASTEURUNK——

Symptoms (2)

No adverse eventWrong product administered

Symptom narrative

they administered Fluzone to a 65 year old patient instead of Fluzone HD with no adverse event; Initial information received on 22-Sep-2025 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 65 year old and unknown gender patient was administered with Influenza Usp Trival A-B Subvirion No Preservative Vaccine [Fluzone] Instead Of Influenza Usp Trival A-B High Dose Subvirion Vaccine [Fluzone High Dose] with no adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date, the patient received an unknown dose of suspect Influenza Usp Trival A-B Subvirion No Preservative Vaccine Suspension for injection (lot number, strength and expiry date-unknown) via unknown route in unknown administration site for prophylactic vaccination (Immunisation) instead of Influenza Usp Trival A-B High Dose Subvirion Vaccine with no adverse event (wrong product administered) (latency-same day). Action taken was not applicable. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.